<--- Back to Details
First PageDocument Content
Biotechnology / Pharmaceutical industry / Drugs / Biopharmaceutical / Pharmacy / Biosimilar / Recombinant DNA / Pharmaceutical drug / Antibody / Small molecule / Lupin Limited
Date: 2015-10-13 04:59:55
Biotechnology
Pharmaceutical industry
Drugs
Biopharmaceutical
Pharmacy
Biosimilar
Recombinant DNA
Pharmaceutical drug
Antibody
Small molecule
Lupin Limited

Add to Reading List

Source URL: www.managingip.com

Download Document from Source Website

File Size: 342,70 KB

Share Document on Facebook

Similar Documents

Biotechnology / Pharmaceutical industry / Drugs / Biopharmaceutical / Pharmacy / Biosimilar / Recombinant DNA / Pharmaceutical drug / Antibody / Small molecule / Lupin Limited

PDF Document

DocID: 1plFE - View Document

Pharmaceuticals policy / Business / Healthcare industry / Economy / Brand / Brand management / Communication design / Graphic design / Pharmaceutical industry in China / Marketing / Generic drug / Lupin Limited

BRDIVISION ANDED GENERIC HEADER PHARM ACEUTIC AL S ABBOT T TODAY

DocID: 1omzN - View Document

LUPIN LIMITED Registered Office: 159, C.S.T. Road, Kalina, Santacruz (East), MumbaiCIN: L24100MH1983PLC029442 Tel.: 2403 Fax: +Website: www.lupinworld.com Email: investorservices@l

DocID: 1gXfb - View Document

NOTICE TO MEMBERS NOTICE is hereby given that the Thirty-Second Annual General Meeting of Lupin Limited will be held at Rang Sharda Natyamandir, Bandra Reclamation, Bandra (West), Mumbai, on Wednesday, July 30,

DocID: 1gWkm - View Document

for tomorrow LUPIN LIMITED l ANNUAL REPORT 2014 Contents Chairman’s Letter

DocID: 1c7pW - View Document